Provided By PR Newswire
Last update: Sep 8, 2025
NEW YORK, Sept. 8, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Sensus Healthcare, Inc. ("Sensus" or the "Company") (NASDAQ: SRTS). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
Read more at prnewswire.comNASDAQ:SRTS (11/28/2025, 8:01:47 PM)
4.19
+0.08 (+1.95%)
Find more stocks in the Stock Screener


